• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Dynamic Biotechnology & Genome Invesco ETF (NY: PBE )

    64.02 -0.22 (-0.34%)
    Official Closing Price Updated: 5:00 PM EDT, Jul 3, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 5,602
    Open 64.32
    Bid (Size) 62.81 (24)
    Ask (Size) 65.15 (23)
    Prev. Close 64.24
    Today's Range 63.79 - 64.49
    52wk Range 52.47 - 67.76
    Shares Outstanding 39,700
    Dividend Yield 0.02%
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    3 Biotech Stocks to Buy That Have CRISPR-Like Breakthrough Potential
    Biotech stocks, namely those involved with gene editing, have been explosive and could see higher highs with strong catalysts. 
    Via InvestorPlace
    Mifepristone Abortion Pill Access in Limbo: Justice Department May Ask Supreme Court's Intervention
    U.S. Attorney General Merrick Garland said that the Justice Department would file an appeal with the U.S. Supreme Court seeking to block the entirety of Kacsmaryk's order suspending the FDA approval of... 
    Via Benzinga

    Performance

    YTD
    -3.87%
    -3.87%
    1 Month
    +0.25%
    +0.25%
    3 Month
    +1.17%
    +1.17%
    6 Month
    -2.65%
    -2.65%
    1 Year
    +5.63%
    +5.63%

    More News

    Read More
    Women's Reproductive Rights: US Court Preserves Access To Abortion Pill For Now, But With Tighter Rules
    Via Benzinga
    New York and California Prepare For Potential Mifepristone Ban In Texas With Stockpiling Of Alternative Abortion Medications
    Via Benzinga
    Attorney Generals of Over 20 States Sound Alarm Over Suspension Of Abortion Med Approval: "Devastating Risks" Ahead
    Via Benzinga
    FDA Withdraws Lone Premature Birth Drug Makena Over Lack of Proven Benefits
    Via Benzinga
    US Judge Weighs Nationwide Ban On Abortion Pills
    Via Benzinga
    FDA Takes Action To Restrict Unlawful Import Of Animal Tranquilizer 'Tranq' Or ''Zombie Drug'
    Via Benzinga
    7 Best Biotech Stocks to Buy in July 2022
    Via InvestorPlace
    Biotech ETFs That Outperformed Last Week
    Via Talk Markets
    A Comprehensive Guide To Genomic ETFs
    Via Talk Markets
    5 Top ETFs With Exposure To Biogen
    Via Talk Markets
    5 Top ETFs With Exposure To Biogen
    Via Benzinga
    Exposures Product Safety
    3 Biotech Stocks Wall Street Predicts Will Rally By 45% Or More
    Via Talk Markets
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.